Skip to content
← Full study record

NCT01602666 · OUTCOME

Estimation of the OS Distribution of Patients With Localized Germinoma Patients and CSF Serum hCGbeta of 50 mIU/mL or Less or CSF Serum hCGbeta Greater Than 50 mIU/mL and Less Than or Equal to 100 mIU/mL

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors · Source last updated 2025-11-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of patients
Interval / dispersion
95% Confidence Interval
Time frame
Up to 3 years

What was measured

Kaplan Meier estimate of the 3-year overall survival (OS) is provided for each group. OS is the time interval measured from enrollment until death from any cause or until last follow-up for those who were alive at the time of analysis. Patients who were lost to follow-up or withdrew consent were censored in this analysis.

Analysis population: The eligible patients with localized germinoma and CSF serum hCGbeta of 50 mIU/mL or less or CSF serum hCGbeta greater than 50 mIU/mL and less than or equal to 100 mIU/mL

Groups in this outcome

hCGbeta <= 50 mIU/mL

CSF/serum hCGbeta \<= 50 mIU/mL

50 mIU/mL < hCGbeta <= 100 mIU/mL

50 mIU/mL \< CSF /serum hCGbeta \<= 100 mIU/mL

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
hCGbeta <= 50 mIU/mL131
50 mIU/mL < hCGbeta <= 100 mIU/mL6

Reported measurements

Source class 1
Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
hCGbeta <= 50 mIU/mL98.38Not reported93.6999.59Not reported
50 mIU/mL < hCGbeta <= 100 mIU/mL100Not reported100100Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        93.69
        upper Limit
        99.59
        value
        98.38
      2. group Id
        OG001
        lower Limit
        100
        upper Limit
        100
        value
        100
denoms
  1. counts
    1. group Id
      OG000
      value
      131
    2. group Id
      OG001
      value
      6
    units
    Participants
description
Kaplan Meier estimate of the 3-year overall survival (OS) is provided for each group. OS is the time interval measured from enrollment until death from any cause or until last follow-up for those who were alive at the time of analysis. Patients who were lost to follow-up or withdrew consent were censored in this analysis.
dispersion Type
95% Confidence Interval
groups
  1. description
    CSF/serum hCGbeta \<= 50 mIU/mL
    id
    OG000
    title
    hCGbeta <= 50 mIU/mL
  2. description
    50 mIU/mL \< CSF /serum hCGbeta \<= 100 mIU/mL
    id
    OG001
    title
    50 mIU/mL < hCGbeta <= 100 mIU/mL
param Type
NUMBER
population Description
The eligible patients with localized germinoma and CSF serum hCGbeta of 50 mIU/mL or less or CSF serum hCGbeta greater than 50 mIU/mL and less than or equal to 100 mIU/mL
reporting Status
POSTED
time Frame
Up to 3 years
title
Estimation of the OS Distribution of Patients With Localized Germinoma Patients and CSF Serum hCGbeta of 50 mIU/mL or Less or CSF Serum hCGbeta Greater Than 50 mIU/mL and Less Than or Equal to 100 mIU/mL
type
SECONDARY
unit Of Measure
percentage of patients

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice